CRO
No Cost Surprises: How Transparent Clinical Trial Budget Builds Trust Between Sponsors and CROs CRO
No Cost Surprises: How Transparent Clinical Trial...

By Niranjan Andhalkar, Director- Strategic Management...

Change Management in Healthcare Consolidation: Ensuring Research Continuity through CROs CRO
Change Management in Healthcare Consolidation: Ens...

By Dr. Peter Sandwall, Founder, CEO, Precision Physic...

Navigating Innovation and Complexity: Trends Shaping the Future of Veterinary CROs CRO
Navigating Innovation and Complexity: Trends Shapi...

By Poala Anfossi, General Manager, Vetspin

Why CROs Are Still Losing the Recruitment Battle – And What Comes Next CRO
Why CROs Are Still Losing the Recruitment Battle –...

By Rose Wang, Founder & CEO, 1104Health

The Changing CRO Environment: Responding to New Models of Service Delivery and Change CRO
The Changing CRO Environment: Responding to New Mo...

By Dr. Diana L. Foster, CEO, Total Diversity Clinical...

The future of drug discovery, testing with computational models and Artificial Intelligence CRO
The future of drug discovery, testing with computa...

By Jana Brajdih Cendak, Medical and Pharmacovigilance...

TaBlitz: A new tablet design software that strives for patient centric drug product design CRO
TaBlitz: A new tablet design software that strives...

By Nelio Drumond, Associate Director, Lead Process Sc...

The AI Revolution in Clinical Trials – Why CROs Need an AI Strategy Now CRO
The AI Revolution in Clinical Trials – Why CROs Ne...

By Dr. Andree Bates, Chairman/Founder/CEO/Artificial...

The Role of Digital Therapeutics in Workplace Mental Health: A Research-Driven Approach CRO
The Role of Digital Therapeutics in Workplace Ment...

By Dr. Brian Alman_Founder, Clinical Director and CEO...

Beyond Search Rankings – AI Reshapes How Life Sciences Share Information Digital Transformation
Beyond Search Rankings – AI Reshapes How Life Scie...

By Haider Alleg, General Partner, Allegory Capital

INNOVATORS
A Pioneer in Early-Phase Clinical Trials
CRO Service Providers List 2026
A Pioneer in Early-Phase Clinical Trials

By Editor Panel, Editor, Lifescience Outlook
An Entrepreneurial Career Largely Defined by Healthcare, Pharmacy & Business Strategy
CEO of the year 2026 - CRO
An Entrepreneurial Career Largely Defined by Healt...

By Editor Panel, Editor, Lifescience Outlook

Celerion
CRO Service Providers List 2026
Celerion

By Editor Panel, Editor, Lifescience Outlook

Enabling Companies Transform Complex Biological Data into Actionable Insights
Digital Transformation Solution Providers List 2026
Enabling Companies Transform Complex Biological Da...

By Editor Panel, Editor, Lifescience Outlook

AI-Driven Solutions Tailored for Life Sciences
Digital Transformation Solution Providers List 2026
AI-Driven Solutions Tailored for Life Sciences

By Editor Panel, Editor, Lifescience Outlook

Magazines

AI in Healthcare Edition 2025
Biotech Special Edition 2025
Digital Transformation Edition 2026
CRO Edition 2026
Related news
Avance Clinical signs MOUs with key Korean trial sites at 2024 KoNECT
CRO
Avance Clinical signs MOUs with key Korean trial sites at 2024 KoNECT
By Editor Panel, Lifescience Outlook, Editor
Progressing the Metabolic Charge
CRO
Progressing the Metabolic Charge
By Editor Panel, Lifescience Outlook, Editor
Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape
CRO
Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials La...
By Editor Panel, Lifescience Outlook, Editor
Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Listing
CRO
Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Li...
By Editor Panel, Lifescience Outlook, Editor
Cencora Puts AI to Work to Improve Patient Access to Medicines
AI in Healthcare
Cencora Puts AI to Work to Improve Patient Access to Medicines
By Editor Panel, Lifescience Outlook, Editor
AI Meets Drug Discovery as Italfarmaco and VeriSIM Life Target New Therapies
Drug Discovery
AI Meets Drug Discovery as Italfarmaco and VeriSIM Life Target New Therapies
By Editor Panel, Lifescience Outlook, Editor